OpenClaw versions prior to 2026.2.22 on macOS contain a path validation bypass vulnerability in the exec-approval allowlist mode that allows local attackers to execute unauthorized binaries by exploiting basename-only allowlist entries. Attackers can execute same-name local binaries ./echo without approval when security=allowlist and ask=on-miss are configured, bypassing intended path-based policy restrictions.
Advisories
Source ID Title
Github GHSA Github GHSA GHSA-7f4q-9rqh-x36p OpenClaw: macOS optional allowlist basename matching could bypass path-based policy
Fixes

Solution

No solution given by the vendor.


Workaround

No workaround given by the vendor.

History

Thu, 19 Mar 2026 22:15:00 +0000

Type Values Removed Values Added
Description OpenClaw versions prior to 2026.2.22 on macOS contain a path validation bypass vulnerability in the exec-approval allowlist mode that allows local attackers to execute unauthorized binaries by exploiting basename-only allowlist entries. Attackers can execute same-name local binaries ./echo without approval when security=allowlist and ask=on-miss are configured, bypassing intended path-based policy restrictions.
Title OpenClaw < 2026.2.22 - Path Traversal via Basename-Only Allowlist Matching on macOS
First Time appeared Openclaw
Openclaw openclaw
Weaknesses CWE-426
CPEs cpe:2.3:a:openclaw:openclaw:*:*:*:*:*:node.js:*:*
Vendors & Products Openclaw
Openclaw openclaw
References
Metrics cvssV3_1

{'score': 7, 'vector': 'CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H'}

cvssV4_0

{'score': 7.3, 'vector': 'CVSS:4.0/AV:L/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N'}


Projects

Sign in to view the affected projects.

cve-icon MITRE

Status: PUBLISHED

Assigner: VulnCheck

Published:

Updated: 2026-03-19T22:06:53.983Z

Reserved: 2026-03-10T19:48:38.211Z

Link: CVE-2026-32016

cve-icon Vulnrichment

No data.

cve-icon NVD

Status : Received

Published: 2026-03-19T22:16:35.027

Modified: 2026-03-19T22:16:35.027

Link: CVE-2026-32016

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.

Weaknesses